Skip to main content

Want a detailed portfolio tracker?

DICE Therapeutics (DICE) EBITDA (2021 - 2023)

DICE Therapeutics (DICE) EBITDA from Sep 30, 2021 to Jun 30, 2023. The TTM DICE Therapeutics (DICE) EBITDA is -$118M. You can adjust inflation or export chart.

Annual EBITDA

Quarterly EBITDA

DICE Therapeutics (DICE) EBITDA CAGR table

PeriodCAGR
1 Year TTM+65.72%

Annual EBITDA change of DICE Therapeutics (DICE)

YearEBITDAChange
2023-$70M-20.19%
2022-$87M+86.20%
2021-$47MN/A